A. Howlett, L. Blume, and G. Dalton, CB1 Cannabinoid Receptors and their Associated Proteins, Current Medicinal Chemistry, vol.17, issue.14, pp.1382-1393, 2010.
DOI : 10.2174/092986710790980023

R. Pertwee, The pharmacology of cannabinoid receptors and their ligands: an overview, International Journal of Obesity, vol.353, pp.13-18, 2006.
DOI : 10.1124/mol.105.016162

J. Wang and N. Ueda, Biology of endocannabinoid synthesis system, Prostaglandins & Other Lipid Mediators, vol.89, issue.3-4, pp.112-119, 2009.
DOI : 10.1016/j.prostaglandins.2008.12.002

D. Marzo, V. Goparaju, S. Wang, and L. , Leptin-regulated endocannabinoids are involved in maintaining food intake, Nature, vol.410, issue.6830, pp.822-825, 2001.
DOI : 10.1038/35071088

C. Silvestri, D. Marzo, and V. , The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders, Cell Metabolism, vol.17, issue.4, pp.475-490, 2013.
DOI : 10.1016/j.cmet.2013.03.001

D. Marzo, V. Després, and J. , CB1 antagonists for obesity???what lessons have we learned from rimonabant?, Nature Reviews Endocrinology, vol.14, issue.11, pp.633-638, 2009.
DOI : 10.1038/nrendo.2009.197

T. Jourdan, L. Djaouti, L. Demizieux, J. Gresti, B. Vergès et al., CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice, Diabetes, vol.59, issue.4, pp.926-934, 2010.
DOI : 10.2337/db09-1482

URL : https://hal.archives-ouvertes.fr/inserm-01344504

R. Nogueiras, C. Veyrat-durebex, and P. Suchanek, Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats, Diabetes, vol.57, issue.11, pp.2977-2991, 2008.
DOI : 10.2337/db08-0161

D. Chanda, D. Kim, and T. Li, Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes, Journal of Biological Chemistry, vol.286, issue.32, pp.27971-27979, 2011.
DOI : 10.1074/jbc.M111.224352

J. Liu, L. Zhou, and K. Xiong, Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice, Gastroenterology, vol.142, issue.5, pp.1218-1219, 2012.
DOI : 10.1053/j.gastro.2012.01.032

D. Osei-hyiaman, J. Liu, and L. Zhou, Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice, Journal of Clinical Investigation, vol.118, issue.9, pp.3160-3169, 2008.
DOI : 10.1172/JCI34827

M. Casu, A. Porcella, and S. Ruiu, Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract, European Journal of Pharmacology, vol.459, issue.1, pp.97-105, 2003.
DOI : 10.1016/S0014-2999(02)02830-3

A. Coutts, A. Irving, K. Mackie, R. Pertwee, and S. Anavi-goffer, Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus, The Journal of Comparative Neurology, vol.20, issue.4, pp.410-422, 2002.
DOI : 10.1002/cne.10270

T. Croci, L. Manara, and G. Aureggi, receptors in human ileum, British Journal of Pharmacology, vol.58, issue.7, pp.1393-1395, 1998.
DOI : 10.1038/sj.bjp.0702190

D. Marzo, V. Capasso, R. Matias, and I. , The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet, British Journal of Pharmacology, vol.167, issue.Suppl 1, pp.1272-1280, 2008.
DOI : 10.1038/sj.bjp.0707682

G. Sanger, Endocannabinoids and the gastrointestinal tract: what are the key questions?, British Journal of Pharmacology, vol.442, issue.3 Suppl, pp.663-670, 2007.
DOI : 10.1038/sj.bjp.0707422

M. Horowitz, M. Edelbroek, J. Wishart, and J. Straathof, Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects, Diabetologia, vol.35, issue.9, pp.857-862, 1993.
DOI : 10.1007/BF00400362

K. Jones, M. Horowitz, M. Wishart, A. Maddox, P. Harding et al., Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus, J Nucl Med, vol.36, pp.2220-2228, 1995.

M. Schwartz, M. Samsom, and W. Renooij, Small Bowel Motility Affects Glucose Absorption in a Healthy Man, Diabetes Care, vol.25, issue.10, pp.1857-1861, 2002.
DOI : 10.2337/diacare.25.10.1857

L. Leiter, A. Ceriello, and J. Davidson, Postprandial glucose regulation: New data andnew implications, Clinical Therapeutics, vol.27, pp.42-56, 2005.
DOI : 10.1016/j.clinthera.2005.11.020

S. Haffner, The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease, Endocrine Reviews, vol.19, issue.5, pp.583-592, 1998.
DOI : 10.1210/edrv.19.5.0343

B. Wagner and W. Galey, Kinetic analysis of hexose transport to determine the mechanism of amygdalin and prunasin absorption in the intestine, Journal of Applied Toxicology, vol.55, issue.5, pp.371-375, 2003.
DOI : 10.1002/jat.934

K. Yamada, M. Hosokawa, and S. Fujimoto, The spontaneously diabetic Torii rat with gastroenteropathy, Diabetes Research and Clinical Practice, vol.75, issue.2, pp.127-134, 2007.
DOI : 10.1016/j.diabres.2006.06.034

T. Jourdan, L. Demizieux, and J. Gresti, Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants, Hepatology, vol.74, issue.Suppl 1, pp.790-799, 2012.
DOI : 10.1002/hep.24733

URL : https://hal.archives-ouvertes.fr/inserm-01344467

D. Antunes, J. Da-costa, and S. Campos, The serum D-xylose test as a useful tool to identify malabsorption in rats with antigen specific gut inflammatory reaction, International Journal of Experimental Pathology, vol.56, issue.1, pp.141-147, 2009.
DOI : 10.1111/j.1365-2613.2008.00627.x

M. Hediger and D. Rhoads, Molecular physiology of sodium-glucose cotransporters, Physiol Rev, vol.74, pp.993-1026, 1994.

D. Deutsch and S. Chin, Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist, Biochemical Pharmacology, vol.46, issue.5, pp.791-796, 1993.
DOI : 10.1016/0006-2952(93)90486-G

L. Phillips, J. Prins, R. Capasso, I. Matias, and B. Lutz, Update on incretin hormones Fatty acid amide hydrolase controls mouse intestinal motility in vivo, Ann N Y Acad Sci Gastroenterology, vol.1243129, pp.55-74, 2005.

L. Pinto, A. Izzo, and M. Cascio, Endocannabinoids as physiological regulators of colonic propulsion in mice, Gastroenterology, vol.123, issue.1, pp.227-234, 2002.
DOI : 10.1053/gast.2002.34242

K. Wright, M. Duncan, and K. Sharkey, receptors in the gastrointestinal tract: a regulatory system in states of inflammation, British Journal of Pharmacology, vol.132, issue.(Suppl 2), pp.263-270, 2008.
DOI : 10.1038/sj.bjp.0707486

A. Izzo and M. Camilleri, Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects, Gut, vol.57, issue.8, pp.1140-1155, 2008.
DOI : 10.1136/gut.2008.148791

L. Drozdowski and A. Thomson, Intestinal sugar transport, World Journal of Gastroenterology, vol.12, issue.11, pp.1657-1670, 2006.
DOI : 10.3748/wjg.v12.i11.1657

R. Chaudhry, J. Scow, S. Madhavan, J. Duenes, and M. Sarr, Acute Enterocyte Adaptation to Luminal Glucose: A Posttranslational Mechanism for Rapid Apical Recruitment of the Transporter GLUT2, Journal of Gastrointestinal Surgery, vol.278, issue.2, pp.312-319, 2012.
DOI : 10.1007/s11605-011-1752-y

G. Kellett, The facilitated component of intestinal glucose absorption, The Journal of Physiology, vol.89, issue.15P, pp.585-595, 2001.
DOI : 10.1111/j.1469-7793.2001.0585h.x

Y. Zheng, J. Scow, J. Duenes, and M. Sarr, Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2, Surgery, vol.151, issue.1, pp.13-25, 2012.
DOI : 10.1016/j.surg.2011.07.010

P. Gonçalves, J. Araújo, I. Azevedo, and F. Martel, Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells, Pharmacology, vol.82, pp.30-37, 2008.

L. Baggio and D. Drucker, Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-2157, 2007.
DOI : 10.1053/j.gastro.2007.03.054

J. Holst, Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors, Expert Opinion on Emerging Drugs, vol.52, issue.1, pp.155-166, 2004.
DOI : 10.2337/diabetes.52.2.380

H. Linnebjerg, S. Park, and P. Kothare, Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes, Regulatory Peptides, vol.151, issue.1-3, pp.123-129, 2008.
DOI : 10.1016/j.regpep.2008.07.003

E. Ogawa, M. Hosokawa, and N. Harada, The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice, Biochemical and Biophysical Research Communications, vol.404, issue.1, pp.115-120, 2011.
DOI : 10.1016/j.bbrc.2010.11.077

L. Hanus, A. Breuer, and S. Tchilibon, HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor, Proceedings of the National Academy of Sciences, vol.96, issue.25, pp.14228-14233, 1999.
DOI : 10.1073/pnas.96.25.14228

M. Duncan, A. Mouihate, and K. Mackie, Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharidetreated rats Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats, Am J Physiol Gastrointest Liver Physiol Br J Pharmacol, vol.295142, pp.78-87, 2004.

F. Mulè, A. Amato, S. Baldassano, and R. Serio, Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations, Pharmacological Research, vol.56, issue.3, pp.185-192, 2007.
DOI : 10.1016/j.phrs.2007.06.002

M. Storr, E. Gaffal, D. Saur, V. Schusdziarra, and H. Allescher, Effect of cannabinoids on neural transmission in rat gastric fundus, Canadian Journal of Physiology and Pharmacology, vol.80, issue.1, pp.67-76, 2002.
DOI : 10.1139/y02-005

D. Bolognini, M. Cascio, D. Parolaro, and R. Pertwee, AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor, British Journal of Pharmacology, vol.149, issue.1, pp.2561-2574, 2012.
DOI : 10.1111/j.1476-5381.2011.01503.x

F. Iannotti, F. Piscitelli, and A. Martella, Analysis of the ???endocannabinoidome??? in peripheral tissues of obese Zucker rats, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.89, issue.2-3, pp.127-135, 2013.
DOI : 10.1016/j.plefa.2013.06.002

R. Capasso and A. Izzo, Gastrointestinal Regulation of Food Intake: General Aspects and Focus on Anandamide and Oleoylethanolamide, Journal of Neuroendocrinology, vol.292, issue.s1, pp.39-46, 2008.
DOI : 10.1074/jbc.M604751200

D. Osei-hyiaman, J. Harvey-white, S. Bátkai, and G. Kunos, The role of the endocannabinoid system in the control of energy homeostasis, International Journal of Obesity, vol.263, pp.33-38, 2006.
DOI : 10.1074/jbc.C500175200